What's on this Page
Role of corticosteroids in CIDP
What is the role of corticosteroids in the treatment of CIDP?
Corticosteroids are an effective treatment for CIDP, and a trial of corticosteroids should be considered in all patients with this condition.
Most patients who respond to prednisone demonstrate a positive effect within 8 weeks of therapy, but high doses (1 mg/kg/day) may be required.
Overall prednisone, prednisolone, or dexamethasone can be used but there is no consensus on whether daily or every other day or intravenous pulse is better.
Sources
- Burns TM: Guillain-Barré syndrome. Semin Neurol 28:152-167, 2008.
- Hughes RA, et al: Supportive care for patients with Guillain-Barré syndrome. Arch Neurol 62:1194-1198, 2005.
- Saperstein DS: Chronic acquired demyelinating polyneuropathies. Semin Neurol 28:168-184, 2008.
- Cocito D, et al: Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Eur J Neurol 18:1417-1421, 2011.
- Joint task force of the EFNS and PNS: European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy . J Periph Nerv Syst 15:1-9, 2010.
- Kleyman I, Brannagan TH: Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Neurol Neurosci Rep 15:47, 2015.
- Hughes RA, Mehndiratta MM: Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev (1):CD002062, 2015.
